EML4-ALK Variant Affects ALK Resistance Mutations

J Clin Oncol. 2018 Apr 20;36(12):1257-1259. doi: 10.1200/JCO.2017.77.2764. Epub 2018 Mar 1.

Authors

Martin Früh¹, Solange Peters¹

Affiliation

¹ Martin Früh, Cantonal Hospital of St Gallen, St Gallen, Switzerland; and Solange Peters, University Hospital of Lausanne, Lausanne, Switzerland.

PMID: 29494260
DOI: 10.1200/JCO.2017.77.2764

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Mutation
Oncogene Proteins, Fusion / genetics
Receptor Protein-Tyrosine Kinases

Substances

EML4-ALK fusion protein, human
Oncogene Proteins, Fusion
Receptor Protein-Tyrosine Kinases